Glenmark Pharmaceuticals

Latest News

Glenmark Pharmaceuticals Receives USFDA Approval To Market Nintedanib Used In The Treatment Of Idiopathic Pulmonary Fibrosis

June 25, 2021 15:38
Healthwire Bureau

Glenmark Pharmaceuticals has received approval from the US health regulator to market Nintedanib capsules, used in the treatment of idiopathic pulmonary fibrosis and non-small cell lung cancer, in the American…

View Post

Latest News
Spotlight

Strides Pharma To Conduct Trials In India For Potential COVID-19 Drug

May 24, 2020 17:47
Healthwire Bureau

New Delhi: Leading pharmaceutical firm Strides Pharma Science has said that it has received regulatory approval to conduct clinical trials of antiviral drug favipiravir, considered a potential treatment for COVID-19.…

View Post

Menu

Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Receives USFDA Approval To Market Nintedanib Used In The Treatment Of Idiopathic Pulmonary Fibrosis

Strides Pharma To Conduct Trials In India For Potential COVID-19 Drug

Winter Heart Attack Alert: 8 Doctor-Approved Lifestyle Changes for Better Cardiovascular Health

Sea Level Set to Rise 1 Metre by 2100, Threatening 14 Million in Coastal Regions: Study Warns

Not Just Smog, Surge in ‘Walking Pneumonia’ Cases Alarms Delhi Residents

Man Declared Dead In Rajasthan Hospital Found Alive Before Last Rites; 4 Doctors Suspended

Breathlessness and Persistent Coughing: Early Signs of a Progressive Lung Disease, Experts Warn

Walking Pneumonia Symptoms: The Silent Respiratory Illness You Could Be Overlooking

Diabetes Treatment Breakthrough: Canagliflozin Improves Kidney Oxygenation, Shows Study

AIIMS Discovers New Drug Combo to Control Hypertension More Effectively